Indaptus Therapeutics

(NASDAQ) INDP

Current Price$2.11

Market Cap$414.47M

Since IPO (2021)-99%

5 Year-99%

1 Year-62%

1 Month+79%

Indaptus Therapeutics Financials at a Glance

Market Cap

$414.47M

Revenue (TTM)

$0.00

Net Income (TTM)

-$18.86M

EPS (TTM)

-$16.05

P/E Ratio

-0.23

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$2.11

Volume

906,722.349

Open

$3.52

Price

$2.11

Volume

906,722.349

Open

$3.52

Previous Close

$3.66

Daily Range

$2.10 - $4.07

52-Week Range

$0.92 - $19.91

Estimated Earnings Date

Aug 17, 2026

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$2.11

Volume

906,722.349

Open

$3.52

Previous Close

$3.66

Daily Range

$2.10 - $4.07

52-Week Range

$0.92 - $19.91

Estimated Earnings Date

Aug 17, 2026

INDP News

Indaptus Posts Narrower Loss in Q2

Motley Fool Markets TeamAug 13, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Indaptus Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David Elliot Lazar; Jeffrey A. Meckler

Website

indaptusrx.com

Headquarters

New York City, NY 10019, US

INDP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-932%

Return on Capital

-14%

Return on Assets

-9%

Earnings Yield

-4.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$414.47M

Shares Outstanding

113.24M

Volume

906.72K

Avg. Volume

802.19K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$19.83M

EBITDA

-$19.83M

Operating Cash Flow

-$14.82M

Capital Expenditure

-$4.00

Free Cash Flow

-$14.82M

Cash & ST Invst.

$8.51M

Total Debt

$0.00

Indaptus Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$414.47M

N/A

Market Cap/Employee

$59.21M

N/A

Employees

N/A

Net Income

-$2.54M

+43.9%

EBITDA

-$2.16M

+52.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$1.50M

-60.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-8.65%

N/A

Return on Invested Capital

-13.96%

N/A

Free Cash Flow

-$7.01M

-38.9%

Operating Cash Flow

-$7.01M

-38.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NKGNNKGen Biotech, Inc. Common Stock

NKGNNKGen Biotech, Inc. Common Stock$0.06+0.00%

SLRXSalarius Pharmaceuticals, Inc.

SLRXSalarius Pharmaceuticals, Inc.$0.84+29.23%

GTBPGT Biopharma, Inc.

GTBPGT Biopharma, Inc.$0.43-2.57%

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.01+2.02%

SLXNSilexion Therapeutics Ltd.

SLXNSilexion Therapeutics Ltd.$5.00+6.96%

ATXIAvenue Therapeutics, Inc.

ATXIAvenue Therapeutics, Inc.$0.31-12.06%

PTIXProtagenic Therapeutics, Inc.

PTIXProtagenic Therapeutics, Inc.$0.50-5.66%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SUNESUNation Energy

SUNESUNation Energy$5.88+4.20%

INHDInno

INHDInno$39.49+36.61%

INTCIntel

INTCIntel$110.18+0.11%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.60+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.26-0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.27+0.04%

NUNu Holdings

NUNu Holdings$11.60-0.03%

Questions About INDP

What is the current price of Indaptus Therapeutics?

Indaptus Therapeutics is trading at $2.10 per share.

What is the 52-week range for Indaptus Therapeutics?

Over the past 52 weeks, Indaptus Therapeutics has traded between $0.92 and $19.91.

How much debt does Indaptus Therapeutics have?

As of the most recent reporting period, Indaptus Therapeutics reported total debt of $0.00.

How much cash does Indaptus Therapeutics have on hand?

Indaptus Therapeutics reported $1.50M in cash and cash equivalents in its most recent financial results.

What is Indaptus Therapeutics’s dividend yield?

Indaptus Therapeutics does not currently have a dividend yield.

Indaptus Therapeutics

Indaptus Therapeutics Financials at a Glance

INDP News

Indaptus Posts Narrower Loss in Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Indaptus Therapeutics

INDP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Indaptus Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About INDP

What is the current price of Indaptus Therapeutics?

What is the 52-week range for Indaptus Therapeutics?

How much debt does Indaptus Therapeutics have?

How much cash does Indaptus Therapeutics have on hand?

What is Indaptus Therapeutics’s dividend yield?

Premium Investing Services